Literature DB >> 32443356

Genetic heterogeneity of pediatric systemic lupus erythematosus with lymphoproliferation.

Guomin Li1, Yifan Li1, Haimei Liu1, Yu Shi1, Wanzhen Guan1, Tao Zhang1, Wen Yao1, Bingbing Wu2, Hong Xu1, Li Sun1.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic, rare autoimmune disease. In recent years, multiple monogenic diseases with early onset autoimmunity and lymphoproliferation have been identified, such as autoimmune lymphoproliferative syndrome, rat sarcoma (RAS)-associated autoimmune leukoproliferative disease, signal transducer and activator of transcription 3 gain-of-function syndrome and interleukin-2 receptor α deficiency. Therefore, we performed whole-exome sequencing in children with SLE with lymphoproliferation to identify genes associated with these conditions.We enrolled 7 patients with SLE with lymphoproliferation from different families. Demographic data, clinical manifestations, laboratory and histopathologic findings, treatment, and outcome were documented. Whole-exome sequencing was performed in 7 patients and their families. Suspected variants were confirmed by Sanger sequencing. Protein levels were detected in patients with gene mutations by western blot.Four patients were male, and 3 were female. No consanguinity was reported within the 7 families. The average age at onset was 5.0 years (range: 1.2-10.0 years). The most common features were renal (7/7 patients) and hematologic (6/7 patients) involvement and recurrent fever (6/7 patients), while only 2 patients presented with skin involvement. Antinuclear antibodies at a titer of ≥1:320 were positive in all patients. All patients fulfilled four 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) criteria for the classification of SLE. We identified a somatic activating NRAS variant (c.38 A>G, p.G13C) in peripheral venous blood from 4 patients, at levels ranging from 8.8% to 42.8% in variant tissues that were absent from their parents. B cell lymphoma (BCL)-2-interacting mediator of cell death levels in peripheral blood mononuclear cells from 4 patients were markedly reduced, whereas those in the control were normal. Another 2 mutations, c.559C>T (p.Q187X) in the TNFAIP3 gene and c.3061G>A (p.E1021K) in the PIK3CD gene were detected in 2 patients.The SLE is a novel phenotype of somatic mutations in the NRAS gene and germline mutations in the PI3CKD gene. These genes, NRAS, TNFAIP3, and PIK3CD, should be considered candidates for children with SLE with lymphoproliferation. If patients with SLE and lymphoproliferation present with renal and hematologic involvement and recurrent fever, they need gene testing, especially male patients.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32443356     DOI: 10.1097/MD.0000000000020232

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  6 in total

1.  Systemic lupus erythematosus as a genetic disease.

Authors:  Isaac T W Harley; Amr H Sawalha
Journal:  Clin Immunol       Date:  2022-02-09       Impact factor: 10.190

2.  Proteomic characterization of four subtypes of M2 macrophages derived from human THP-1 cells.

Authors:  Pengfei Li; Chen Ma; Jing Li; Shanshan You; Liuyi Dang; Jingyu Wu; Zhifang Hao; Jun Li; Yuan Zhi; Lin Chen; Shisheng Sun
Journal:  J Zhejiang Univ Sci B       Date:  2022-05-15       Impact factor: 5.552

3.  Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge.

Authors:  Aleksandra Szczawińska-Popłonyk; Elzbieta Grześk; Eyal Schwartzmann; Anna Materna-Kiryluk; Jadwiga Małdyk
Journal:  Front Pediatr       Date:  2021-12-30       Impact factor: 3.418

4.  A case of refractory systemic lupus erythematosus with monocytosis exhibiting somatic KRAS mutation.

Authors:  Sze-Ming Law; Shuji Akizuki; Akio Morinobu; Koichiro Ohmura
Journal:  Inflamm Regen       Date:  2022-04-01

Review 5.  Druggable monogenic immune defects hidden in diverse medical specialties: Focus on overlap syndromes.

Authors:  Valentina Boz; Chiara Zanchi; Laura Levantino; Guglielmo Riccio; Alberto Tommasini
Journal:  World J Clin Pediatr       Date:  2022-03-09

Review 6.  Vasculitis, Autoimmunity, and Cytokines: How the Immune System Can Harm the Brain.

Authors:  Alessandra Tesser; Alessia Pin; Elisabetta Mencaroni; Virginia Gulino; Alberto Tommasini
Journal:  Int J Environ Res Public Health       Date:  2021-05-24       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.